Events O, A and B for the three time delay quantities. by Thomas Ward (688068)

Scenario 1: Budget impact of a 20% decrease in the proposed market share of ENG. by Agnaldo Lopes da Silva Filho (18271556)

“…<p>Scenario 1: Budget impact of a 20% decrease in the proposed market share of ENG.…”

Effect sizes for the total market, the live market, and the recorded market. by Janis Denk (12542776)

Violin plots of the best fit modelled distributions of times to clinical outcome over the course of the pandemic for category A. by Thomas Ward (688068)

Expression of lipid biosynthetic genes is decreased with polyamine depletion. by Yazmin E. Cruz-Pulido (20285238)

Performance on increasingly large data sets. by Kieran Elmes (11127506)

Cinacalcet administered early in the inactive phase markedly decrease parathyroid Ki-67 index. by Søren Egstrand (10906087)

Marking example. by Qingjun Yu (1649473)

Group-level narrow- and broad-band spectral changes after hemispherotomy reveal a marked EEG slowing of the isolated cortex, robust across patients. by Michele Angelo Colombo (22446342)

A summary of conditions with decreased RRs (Bayesian, US inpatient). by Hanxin Zhang (4280524)

A summary of conditions with decreased RRs (frequentist, US inpatient). by Hanxin Zhang (4280524)

Brief Report: Increased technology use associated with lower A1C in a large pediatric clinical population by G. Todd Alonso (9568724)

A summary of conditions with decreased RRs (Bayesian, US all-patient). by Hanxin Zhang (4280524)

A summary of conditions with decreased RRs (frequentist, US all-patient). by Hanxin Zhang (4280524)

Deletion of <i>sagA</i> alone results in a decrease in nasopharyngeal infection. by Blake A. Shannon (14197601)

Phytoplankton Increase Along the Kuroshio Due to the Large Meander by Takeyoshi Nagai (9249758)

An all-author-suggested panel of reviewers produces a large increase in the acceptance rate of a manuscript. by Daniel E. Acuna (3158904)

Table1_Biosimilar competition in European markets of TNF-alpha inhibitors: a comparative analysis of pricing, market share and utilization trends.DOCX by Elif Car (15336148)

“…Descriptive analyses were conducted based on the evolution in price per DDD, trends in biosimilar and originator market shares and utilization trends.</p><p>Results: Market entry of the first biosimilars of infliximab and adalimumab resulted in a decrease of the volume-weighted average price (VWAP) per DDD by 13.6% and 0.9% on average, whilst the second biosimilars resulted in a decrease by 26.4% and 27.3%, respectively. …”

Largest twenty coefficients by absolute value as defined by logistic regression. by Roshan Karri (11060943)

Effects of increased epithelial cell contractility on the large intestine. by Taylor Hinnant (18239604)